In a randomized trial of 92 adults with metabolic syndrome, EGCG (400 mg/day for 8 weeks) increased the abundance of Lactobacillus rhamnosus and Bifidobacterium breve, with concurrent reductions in zonulin and VCAM-1 [49]. The gene discussed is VCAM1; the disease is metabolic syndrome.